Morgan Stanley’s Vivani Medical VANI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $341 | Hold |
341
| – | – | ﹤0.01% | 7658 |
|
|
2025
Q4 | $419 | Sell |
341
-98
| -22% | -$142 | ﹤0.01% | 7529 |
|
|
2025
Q3 | $619 | Buy |
439
+13
| +3% | +$18 | ﹤0.01% | 7459 |
|
|
2025
Q2 | $550 | Buy |
426
+8
| +2% | +$9 | ﹤0.01% | 7431 |
|
|
2025
Q1 | $439 | Hold |
418
| – | – | ﹤0.01% | 7394 |
|
|
2024
Q4 | $485 | Hold |
418
| – | – | ﹤0.01% | 7347 |
|
|
2024
Q3 | $489 | Sell |
418
-148
| -26% | -$185 | ﹤0.01% | 7300 |
|
|
2024
Q2 | $713 | Hold |
566
| – | – | ﹤0.01% | 7191 |
|
|
2024
Q1 | $1.05K | Sell |
566
-1,066
| -65% | -$1.57K | ﹤0.01% | 7170 |
|
|
2023
Q4 | $1.66K | Buy |
1,632
+816
| +100% | +$809 | ﹤0.01% | 7155 |
|
|
2023
Q3 | $832 | Hold |
816
| – | – | ﹤0.01% | 7258 |
|
|
2023
Q2 | $987 | Sell |
816
-1,133
| -58% | -$1.4K | ﹤0.01% | 7296 |
|
|
2023
Q1 | $1.95K | Hold |
1,949
| – | – | ﹤0.01% | 7239 |
|
|
2022
Q4 | $1.66K | Sell |
1,949
-4,671
| -71% | -$7.61K | ﹤0.01% | 7401 |
|
|
2022
Q3 | $15K | Sell |
6,620
-70,938
| -91% | -$337K | ﹤0.01% | 6929 |
|
|
2022
Q2 | $472K | Sell |
77,558
-110,178
| -59% | -$594K | ﹤0.01% | 5453 |
|
|
2022
Q1 | $805K | Sell |
187,736
-158,343
| -46% | -$666K | ﹤0.01% | 5122 |
|
|
2021
Q4 | $1.69M | Buy |
346,079
+296,477
| +598% | +$2.17M | ﹤0.01% | 4696 |
|
|
2021
Q3 | $474K | Buy |
49,602
+48,804
| +6,116% | +$550K | ﹤0.01% | 5533 |
|
|
2021
Q2 | $12K | Sell |
798
-19
| -2% | -$367 | ﹤0.01% | 7189 |
|
|
2021
Q1 | $20K | Sell |
817
-2,652
| -76% | -$39.6K | ﹤0.01% | 6719 |
|
|
2020
Q4 | $19K | Hold |
3,469
| – | – | ﹤0.01% | 6451 |
|
|
2020
Q3 | $9K | Sell |
3,469
-4
| -0.1% | -$10 | ﹤0.01% | 6308 |
|
|
2020
Q2 | $10K | Sell |
3,473
-56
| -2% | -$199 | ﹤0.01% | 6162 |
|
|
2020
Q1 | $11K | Buy |
3,529
+3,445
| +4,101% | +$45.5K | ﹤0.01% | 5993 |
|
|
2019
Q4 | $1K | Sell |
84
-8
| -9% | -$157 | ﹤0.01% | 6594 |
|
|
2019
Q3 | $2K | Sell |
92
-20
| -18% | -$394 | ﹤0.01% | 6492 |
|
|
2019
Q2 | $2K | Buy |
112
+13
| +13% | +$267 | ﹤0.01% | 6476 |
|
|
2019
Q1 | $2K | Sell |
99
-25
| -20% | -$487 | ﹤0.01% | 6472 |
|
|
2018
Q4 | $2K | Sell |
124
-173
| -58% | -$5.51K | ﹤0.01% | 6440 |
|
|
2018
Q3 | $14K | Buy |
297
+153
| +106% | +$6.17K | ﹤0.01% | 6231 |
|
|
2018
Q2 | $6K | Sell |
144
-349
| -71% | -$15.2K | ﹤0.01% | 6411 |
|
|
2018
Q1 | $23K | Buy |
493
+131
| +36% | +$5.83K | ﹤0.01% | 6098 |
|
|
2017
Q4 | $17K | Buy |
362
+235
| +185% | +$7.81K | ﹤0.01% | 6119 |
|
|
2017
Q3 | $3K | Sell |
127
-1,185
| -90% | -$33.1K | ﹤0.01% | 6369 |
|
|
2017
Q2 | $40K | Sell |
1,312
-59
| -4% | -$1.67K | ﹤0.01% | 5915 |
|
|
2017
Q1 | $39K | Sell |
1,371
-713
| -34% | -$27.3K | ﹤0.01% | 5909 |
|
|
2016
Q4 | $98K | Buy |
2,084
+1,327
| +175% | +$75.8K | ﹤0.01% | 5577 |
|
|
2016
Q3 | $65K | Buy |
757
+166
| +28% | +$14.7K | ﹤0.01% | 5483 |
|
|
2016
Q2 | $51K | Sell |
591
-135
| -19% | -$14K | ﹤0.01% | 5523 |
|
|
2016
Q1 | $84K | Buy |
726
+119
| +20% | +$13.7K | ﹤0.01% | 5390 |
|
|
2015
Q4 | $85K | Sell |
607
-418
| -41% | -$61.2K | ﹤0.01% | 5489 |
|
|
2015
Q3 | $146K | Sell |
1,025
-176
| -15% | -$48.9K | ﹤0.01% | 5241 |
|
|
2015
Q2 | $392K | Buy |
1,201
+593
| +98% | +$190K | ﹤0.01% | 4877 |
|
|
2015
Q1 | $186K | Sell |
608
-2,245
| -79% | -$624K | ﹤0.01% | 5250 |
|
|
2014
Q4 | $702K | Buy |
+2,853
| New | +$995K | ﹤0.01% | 4438 |
|
Other funds holding VANI
VCM
TWM
VFT
MMG
Morgan Stanley's VANI Position: Q1 2026 in Review
Morgan Stanley held its Vivani Medical (VANI) position steady in Q1 2026 at 341 shares worth $341. The position accounts for ﹤0.01% of the portfolio, ranked #7658.
Morgan Stanley first reported a position in VANI in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.69M in Q4 2021. 43 funds tracked by Wall St. Rank hold VANI as of Q1 2026.
- Morgan Stanley held 341 shares of Vivani Medical worth $341 as of Q1 2026.
- Morgan Stanley left its Vivani Medical share count unchanged in Q1 2026.
- Vivani Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7658 holding.
- Morgan Stanley first reported a position in Vivani Medical in Q4 2014 and has held it in 46 quarters since.
- Morgan Stanley's Vivani Medical position peaked at $1.69M in Q4 2021.
- 43 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.